2nd Quarter - Report

MEDIMMUNE, LLC. for MEDIMMUNE LLC

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 475 A bill to amend the Vaccine Injury Compensation Program; Issues related to Medicaid coverage and reimbursement of respiratory syncytial virus (RSV) prophylaxis and federal quality strategies for prevention of RSV; Medicaid coverage and reimbursement of biologics; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act

Foreign entity interest: MedImmune, LLC is a subsidiary of AstraZeneca, Inc.

LobbyistCovered position, as disclosed
ANDREA WILKINSON —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3590 (113th), H.R. 475 (113th)

Budget/Appropriations BUD

Proposed FY2014 Budgets Congressional and White House budgets--health care related provisions. Proposed FY2014 Labor, HHS; Ag and DOD Appropriations BARDA, pandemic planning & preparedness

Foreign entity interest: MedImmune, LLC is a subsidiary of AstraZeneca, Inc.

LobbyistCovered position, as disclosed
ANDREA WILKINSON —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Manufacturing MAN

Issues effecting the secure supply chain of pharmaceutical distribution

Foreign entity interest: MedImmune, LLC is a subsidiary of AstraZeneca, Inc.

LobbyistCovered position, as disclosed
ANDREA WILKINSON —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.